Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.kidney-international.org › article › S0085-2538(22)00507-5KDIGO 2022 Clinical Practice Guideline for ... - Kidney...

   www.kidney-international.org › article › S0085-2538(22)00507-5

   21 cze 2022 · The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating diabetes and CKD.

   • Secrets and Myths Between Tubules – New Insights on Erythropoietin Production From Single Cell Technology

     Where within the kidney erythropoietin (EPO) is produced and...

   • Kdigo 2021 Clinical Practice Guideline for The Management of Glomerular Diseases

     This guideline is published as a supplement supported by...

   • The Nijmegen Biomedical Study

     The Nijmegen Biomedical Study is a population-based...

   • Reconceptualizing Podocyte Damage in Fabry Disease: New Findings Identify Alpha-Synuclein as a Putative Therapeutic Target

     Fabry disease (FD, OMIM #301500) is an X-linked genetic...

   • Kdigo 2021 Clinical Practice Guideline for The Management of Blood Pressure in Chronic Kidney Disease

     The development and publication of this guideline were...

2. www.kidney-international.org › article › S0085-2538(20)30718-3KDIGO 2020 Clinical Practice Guideline for ... - Kidney...

   www.kidney-international.org › article › S0085-2538(20)30718-3

   Since 2003, KDIGO has developed a catalog of clinical practice guidelines informing the care of patients with, or at risk of developing, kidney diseases. Currently, KDIGO is updating 2 existing guidelines on Blood Pressure in CKD and Glomerular Diseases, respectively.

3. journals.sagepub.com › doi › fullRecommended Methods of Drug Dosing Adjustment for Patients With...

   journals.sagepub.com › doi › full

   11 gru 2023 · This commentary provides an overview of recent recommendations concerning kidney function assessment that have important implications for drug dosing in patients with renal impairment and provides suggestions for implementing these recommendations.

4. kdigo.org › wp-content › uploadsDrug dosing consideration in patients with acute and chronic...

   kdigo.org › wp-content › uploads

   Drug dosage adjustment for patients with acute or chronic kidney disease is an accepted standard of practice. The challenge is how to accurately estimate a patient’s kidney function in both acute and chronic kidney disease and determine the influence of renal replacement therapies on drug disposition. Kidney Disease: Improving Global

5. www.ncbi.nlm.nih.gov › books › NBK560512Renal Failure Drug Dose Adjustments - StatPearls - NCBI Bookshelf

   www.ncbi.nlm.nih.gov › books › NBK560512

   27 lip 2024 · In addition, drug factors, including the drug excretion and the therapeutic index, must be considered when adjusting doses. Accurate estimation of renal function is crucial for determining appropriate doses of renally excreted drugs.

6. www.ncbi.nlm.nih.gov › pmc › articlesHow to adjust drug doses in chronic kidney disease - PMC

   www.ncbi.nlm.nih.gov › pmc › articles

   1 paź 2019 · Examples include changing a patient with chronic kidney disease from metformin to a sulfonylurea (lower effectiveness and reduced long-term benefit), or rivaroxaban to warfarin (narrower therapeutic index and requiring more blood tests).

7. www.aafp.org › pubs › afpDrug Dosing Adjustments in Patients with Chronic Kidney Disease -...

   www.aafp.org › pubs › afp

   • Zapisane w pamięci cache

   15 maj 2007 · Dosages of drugs cleared renally should be adjusted according to creatinine clearance or glomerular filtration rate and should be calculated using online or electronic calculators. Recommended...